Cargando…
Two cases of type 2 diabetes mellitus in elderly patients successfully treated with monthly exenatide long‐acting release
Two elderly patients with poorly controlled type 2 diabetes mellitus had difficulty self‐managing their medications. Exenatide long‐acting release (LAR), with an extended administration interval of 1 month, maintained hemoglobin A1c (HbA1c) level in the 7% range. Monthly administration of exenatide‐...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6509896/ https://www.ncbi.nlm.nih.gov/pubmed/31110729 http://dx.doi.org/10.1002/ccr3.2139 |